Osteoarthritis

In a Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, offered a breakdown of the October issue, including the cover story which delved into the topic of individualized precision medicine.

Patients with osteoarthritis who undergo arthroscopic partial meniscectomy appear to demonstrate greater OARSI score progression via osteophytes, but not Kellgren-Lawrence grades, according to data published in Arthritis Care & Research.

For patients with diseases such as lupus or rheumatoid arthritis who take low-dose drugs at lower frequencies, the relief afforded by over-the-counter drugs such as ibuprofen and naproxen can be a boon.

Patients with osteoarthritis who experience neck pain lasting longer than 1 year have a significant increased risk for all-cause mortality, according to data published in Arthritis Research & Therapy.

Patients with rheumatoid arthritis or osteoarthritis in rural areas are less likely to report in-person health care use, including physician visits and diagnostic tests, vs. those in urban areas, according to data.

Among older adults enrolled in an osteoarthritis cohort, those with foot symptoms such as pain and stiffness demonstrated a higher risk for death vs. those without foot symptoms, according to data published in Arthritis Care & Research.

Patients with intra-articular mineralization demonstrate a two-times higher likelihood of having frequent knee pain, as well as more intermittent or constant pain, according to data published in Arthritis & Rheumatology.

EP-104AR, an injectable form of fluticasone propionate designed slowly distribute through the knee joint and provide pain relief for up to 6 months, improved pain vs. a placebo over 12 weeks, according to the manufacturer.

SAN DIEGO — Mitigating infection risks while preventing flares is often a balancing act for rheumatologists managing patients undergoing hip or knee replacement, according to a presenter at the 2023 Congress of Clinical Rheumatology West.

SAN DIEGO — The ability to recognize common osteoarthritis risk factors will become increasingly critical in the coming decades, as recent data project the global prevalence of the disease will reach 1 billion by 2050, noted a speaker here.